Growth in operating cash flow is phenomenal:
Q4 24 $440 million USD Q4 23 $ 237 million USD
FY 24 $ 1,401 million USD FY 23 $ 693 million USD
Allowing a massive reduction in net liabilities:
June 30, 2024 $ 2,008 million USD June 30, 2023 $ 2,621 million USD
This business is a powerhouse. And as a very satisfied customer, it is also dramatically improving the quality of my life along with millions of others.
- Forums
- ASX - By Stock
- Ann: ResMed Announces Results for the Fourth Quarter of FY2024
Growth in operating cash flow is phenomenal:Q4 24 $440 million...
Featured News
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$36.66 |
Change
-0.940(2.50%) |
Mkt cap ! $22.39B |
Open | High | Low | Value | Volume |
$36.32 | $36.69 | $36.13 | $46.16M | 1.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 177 | $36.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$36.71 | 12610 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 177 | 36.600 |
1 | 32 | 36.500 |
1 | 1578 | 36.490 |
2 | 3711 | 36.480 |
2 | 110 | 36.460 |
Price($) | Vol. | No. |
---|---|---|
36.710 | 12610 | 4 |
36.720 | 700 | 1 |
36.740 | 627 | 2 |
36.750 | 6200 | 1 |
36.920 | 100 | 1 |
Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
Featured News
RMD (ASX) Chart |